Early-Stage Innovation Forum at AusMedtech 2025

The Early-Stage Innovation Forum (ESIF) at AusMedtech 2025 will spotlight Australia’s emerging technologies, offering an exclusive platform for innovators to present their groundbreaking projects to industry experts and investors. This is your chance to showcase your technology, gain valuable feedback from an expert panel, and connect with investors to accelerate your commercialisation journey.

Taking place on Wednesday, 7 May at ICC Sydney, the forum will feature rapid-fire presentations from research institutes, universities, hospitals, and pre-series A companies. Presentations will focus on cutting-edge innovations in:

  • Medical devices and diagnostics

  • Digital health

  • Enabling technologies

Meet our ESIF Advisory Panel

 

AusMedtech 2025 ESIF Presenting Companies

Dohme

Madelaine Pankhurst, Founder

Developing a wearable headset that combines real-time brain monitoring with personalised neurostimulation to manage and treat concussion, enabling remote tracking and adaptive recovery interventions.

Garvan Institute of Medical Research

Shanon Ranjit, Senior R&D Scientist

Developing a blood and urine test that detects kidney damage within an hour by identifying a unique kidney-specific DNA marker, enabling earlier diagnosis and intervention for acute kidney injury.

INOPASE Pty Ltd

Munemasa Sugimoto, Director

Developing a closed-loop sacral neuromodulation system that senses bladder nerve activity and delivers precision stimulation to improve treatment outcomes for patients with overactive bladder.

Isochem Solutions

Prof. Anthony Dosseto, Director

Developing a simple urine and blood test to assess osteoporosis and bone health, offering a more accurate, non-invasive alternative to DEXA scans. Already validated overseas, the project is now focused on adapting it for Australia.

Luminoma Diagnostics Ltd

Maher Khaled, CEO

Developing a portable, non-invasive device that quickly indicates whether a skin lesion is malignant or benign, helping clinicians reduce unnecessary biopsies and find cancers earlier.

Murdoch Children's Research Institute

Megan Nagarajah, Innovation Manager

Developing a wearable, cuffless blood pressure monitor that provides continuous, accurate readings for infants and children without causing distress or requiring them to stay still.

Pulsatile Innovations Pty Ltd

Elleesha King, Founder/CEO

Developing a pulse-sensing device placed on the neck to help rescuers quickly identify cardiac arrest, guide CPR decisions, and improve survival and neurological outcomes.

University Of Melbourne

Dr. Camilla Tuttle, Program Manager

Developing a surgical kit that uses a patient’s own tissue and a biodegradable gel to regenerate knee cartilage in a one-step procedure, aiming to prevent early onset osteoarthritis.

UNSW

Theatin van Leeuwen, Phd Candidate

Developing polymeric particles delivered via capsules to reduce hydrogen sulfide levels in the colon, targeting improved management of conditions such as IBS, IBD, and colorectal cancer risk.